The Franklin Lakes-based medical technology company will be able to further meet the needs of retail pharmacies, including those in outpatient settings.

Nikita Lynn came on board to the Parsippany-based firm in August 2020, prior to that she spent six years at accounting giant PwC, where she was in the assurance department and then senior manager for her last year.

State health officials have warily eyed the presence of these new variants, which they said are slated to drive back up daily cases and total COVID-19 patient count.

Thanks to the infusion of Johnson & Johnson’s one-shot vaccine Gov. Phil Murphy believes the supplies of all the COVID vaccines on either side of Easter are going to explode.

Rhonda Jordan has been named executive vice president and chief human resources officer and Stephanie Fendrick has been named executive vice president and chief strategy officer.

The Jersey City-based biotech company said its oral ibrexafungerp showed clinical benefit in eight out of ten patients studied combating serious life-threatening fungal infections.

“These variants are a very real threat to our people and our progress,” CDC Director Dr. Rochelle Walensky said during a March 1 White House press briefing. “Now is not the time to relax the critical safeguards that we know can stop the spread of COVID-19 in our communities, not when we are so close.”

The pharmaceutical giants will combine forces to help produce a single shot vaccine.

The CEO of Bridgewater-based Insmed discusses the company's products -- which target rare and serious diseases, including COVID-19, his outlook for the next several months and the role BioNJ, for which he now serves as chairman, can and should play in the state's health care industry.

Anthony Mahajan has come on board to Pine Brook-based Frier Levitt LLC to chair its white collar defense and government investigations practice, and as a partner in its litigation and regulatory departments.

Frank Dos Santos’s expertise in global health care and medical research will be a perfect blend for the leadership team and for the community at the Belleville medical center.

The three-phase program uses the latest research to help patients recuperate by customizing treatment specific to each patient to help them regain strength and functional abilities following COVID-19.